12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movements in Monday's intraday session. Landos Biopharma's shares surged by 173.9% following their Q4 earnings report. Other notable gainers include Altamira Therapeutics, XTL Biopharmaceuticals, Nkarta, Sagimet Biosciences, and Molecular Templates. On the downside, Trxade Health led the losers with a 48.6% drop, followed by declines in SINTX Techs, Akanda, Invivyd, 180 Life Sciences, and Kineta.
March 25, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Trxade Health's stock plummeted by 48.6% to $12.38, with a market cap of $14.9 million.
Trxade Health's significant stock price decline could indicate negative market sentiment or reactions to recent company developments.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Altamira Therapeutics' stock rose by 30.63% to $2.26, with a market value of $4.1 million.
Altamira Therapeutics' stock increase suggests positive investor response, potentially due to recent company achievements or market conditions.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Landos Biopharma's stock surged 173.9% to $21.45 after their Q4 earnings report, with a market cap of $66.8 million.
The significant surge in Landos Biopharma's stock price is directly attributed to their recent Q4 earnings report, indicating strong investor confidence.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Nkarta's shares rose by 23.87% to $11.05 following their Q4 earnings report, with a market cap of $542.2 million.
Nkarta's stock increase is directly linked to their recent Q4 earnings report, indicating positive investor reception.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Sagimet Biosciences' stock increased by 23.05% to $5.55 after their FY earnings, with a market value of $177.0 million.
The increase in Sagimet Biosciences' stock price is attributed to their recent FY earnings report, reflecting positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
XTL Biopharmaceuticals' shares increased by 28.24% to $3.36, with a market cap of $18.3 million.
The rise in XTL Biopharmaceuticals' stock price could be driven by positive market sentiment or recent company news.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90